Literature DB >> 30806495

The consensus of integrative diagnosis and treatment of acute pancreatitis-2017.

Junxiang Li1, Jing Chen1, Wenfu Tang1.   

Abstract

Acute pancreatitis (AP) is one of the most common acute abdominal diseases. The digestive disease committee, Chinese Association of Integrative Medicine, released Integrated traditional Chinese and Western medicine for diagnosis and treatment of acute pancreatitis in 2010.1 Since then, further studies and great progress have been made by domestic and foreign counterparts from the perspective of both Chinese and Western medicine in AP, including the classification, fluid resuscitation, organ function maintenance, surgery intervention, enteral nutrition (EN), and syndrome differentiation and treatment. It is necessary to update the consensus on diagnosis and treatment of integrated Chinese and Western medicine to meet clinical needs. Therefore, the 2012 Revision of the Atlanta Classification Standard (RAC) by the International AP Consensus,2 the 2013 the Management of Acute Pancreatitis by the American College of Gastroenterology,3, 4 the 2014 Guidelines for diagnosis and treatment of the acute pancreatitis guide (2014) by the Chinese medical association branch,5 the 2014 Guidelines on Integrative Medicine for Severe Acute Pancreatitis by the General Surgery Committee of the Chinese Society of Integrated Traditional Chinese and Western Medicine,6 and Traditional Chinese Medicine Consensus on the Diagnosis and Treatment for Acute Pancreatitis by the Spleen and Stomach committee of China Association of Traditional Chinese Medicine7, 8 were taken into account for the revision of the consensus published in 2010. The digestive specialists in Chinese and Western medicine had a discussion on traditional Chinese medicine (TCM) types, syndrome differentiation, the main points of integrative medicine, and so on. According to the Delphi method, Consensus of Integrative Diagnosis and Treatment of Acute Pancreatitis (the 2017 revision) has been passed after three rounds votes. (The voting options are as follows: (a) totally agree; (b) agree, but with some reservations; (c) agree, but with larger reservations; (d) disagree, but reserved; and (e) absolutely disagree. If more than two out of three choose (a), or over 85% choose (a) + (b), the consensus will be passed.) The final validation was carried out by the core expert group in Taizhou, Jiangsu on June 9, 2017. The full text is as follows.
© 2019 Chinese Cochrane Center, West China Hospital of Sichuan University and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  acute pancreatitis; consensus; diagnosis and treatment; integrative medicine

Mesh:

Year:  2019        PMID: 30806495     DOI: 10.1111/jebm.12342

Source DB:  PubMed          Journal:  J Evid Based Med        ISSN: 1756-5391


  13 in total

1.  Interfering hsa_circ_0073748 alleviates caerulein-induced ductal cell injury in acute pancreatitis by inhibiting miR-132-3p/TRAF3/NF-κB pathway.

Authors:  Song Ren; Longfei Pan; Linqing Yang; Zequn Niu; Liming Wang; Yanxia Gao; Jie Liu; Zhong Liu; Honghong Pei
Journal:  Cell Cycle       Date:  2021-12-09       Impact factor: 4.534

2.  Early Versus Delayed Laparoscopic Cholecystectomy for Acute Cholecystitis with Mild Pancreatitis.

Authors:  Lu Wang; Hai-Feng Yu; Tong Guo; Peng Xie; Zhi-Wei Zhang; Ya-Hong Yu
Journal:  Curr Med Sci       Date:  2020-10-29

3.  Current diagnosis and treatment of acute pancreatitis in China: a real-world, multicenter study.

Authors:  Chuandong Sun; Zhu Li; Zheng Shi; Guichen Li
Journal:  BMC Gastroenterol       Date:  2021-05-08       Impact factor: 3.067

4.  Assessment of Computed Tomography-Defined Muscle and Adipose Tissue Features in Relation to Length of Hospital Stay and Recurrence of Hypertriglyceridemic Pancreatitis.

Authors:  Huajun Yu; Yingbao Huang; Lifang Chen; Liuzhi Shi; Yunjun Yang; Weizhi Xia
Journal:  Int J Gen Med       Date:  2021-05-05

5.  Da Cheng Qi Decoction Alleviates Cerulein-Stimulated AR42J Pancreatic Acinar Cell Injury via the JAK2/STAT3 Signaling Pathway.

Authors:  Zehua Zhou; Ying Chen; Wenmin Dong; Rui An; Kun Liang; Xinhong Wang
Journal:  Evid Based Complement Alternat Med       Date:  2021-04-09       Impact factor: 2.629

6.  Appraisal of the diagnostic procedures of acute pancreatitis in the guidelines.

Authors:  Ke-Qian Yi; Ting Yang; Yan-Min Yang; Guo-Li Lan; Li-Ya An; Yu-Xing Qi; Hong-Bo Fan; Yong-Qing Duan; Da-Li Sun
Journal:  Syst Rev       Date:  2021-01-09

Review 7.  A narrative review of acute pancreatitis and its diagnosis, pathogenetic mechanism, and management.

Authors:  Zhi Zheng; Yi-Xuan Ding; Yuan-Xu Qu; Feng Cao; Fei Li
Journal:  Ann Transl Med       Date:  2021-01

8.  The visceral adiposity index predicts the severity of hyperlipidaemic acute pancreatitis.

Authors:  Weizhi Xia; Huajun Yu; Yingbao Huang; Yunjun Yang; Liuzhi Shi
Journal:  Intern Emerg Med       Date:  2021-08-02       Impact factor: 3.397

9.  P-selectin glycoprotein ligand 1 deficiency prevents development of acute pancreatitis by attenuating leukocyte infiltration.

Authors:  Xu Zhang; Ming Zhu; Xiao-Liang Jiang; Xing Liu; Xue Liu; Pan Liu; Xian-Xian Wu; Zhi-Wei Yang; Tao Qin
Journal:  World J Gastroenterol       Date:  2020-11-07       Impact factor: 5.742

10.  Circulating Blood miR-155 and miR-21 Promote the Development of Acute Pancreatitis and Can Be Used to Assess the Risk Stratification of Pancreatitis.

Authors:  Lan Hu; Dongdong Han; Diao Yu; Dongji Ao; Zhengyi Yang
Journal:  J Healthc Eng       Date:  2021-12-14       Impact factor: 2.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.